Immediate Impact
65 standout
Citing Papers
Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association
2025 Standout
Pharmacological treatment for metabolic dysfunction–associated steatotic liver disease and related disorders: Current and emerging therapeutic options
2025 Standout
Works of Yusuf Kayar being referenced
Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Yusuf Kayar | 172 | 79 | 180 | 86 | 68 | 457 | |
| Endrit Shahini | 116 | 73 | 208 | 57 | 48 | 462 | |
| Adrian Boicean | 163 | 37 | 114 | 156 | 58 | 463 | |
| Abdullah Özgür Yeniova | 195 | 136 | 196 | 36 | 42 | 495 | |
| Selim Gökçe | 162 | 65 | 135 | 28 | 30 | 424 | |
| Daniel Vasile Balaban | 249 | 185 | 153 | 39 | 65 | 504 | |
| Maşallah Baran | 230 | 133 | 98 | 55 | 68 | 485 | |
| Alpaslan Tanoğlu | 171 | 22 | 181 | 82 | 95 | 487 | |
| Prasun K. Jalal | 86 | 20 | 163 | 62 | 55 | 448 | |
| Eugen Dumitru | 140 | 39 | 137 | 76 | 58 | 408 | |
| Dragan Popović | 139 | 34 | 202 | 52 | 44 | 432 |
All Works
Login with ORCID to disown or claim papers
Loading papers...